Objective. To assess nailfold capillary density and dimensions in patients with primary Raynaud's phenomenon (PRP), limited cutaneous systemic sclerosis (LSSc) and diffuse cutaneous SSc (DSSc), and healthy control subjects.
The technique of widefield capillary microscopy is now nomenon (PRP), 10 patients with SSc and 10 healthy well established in the assessment of patients with control subjects [3] . We found that patients with PRP Raynaud's phenomenon and systemic sclerosis (SSc) had increased dimensions compared with controls, and [1] : capillary dilation and loop drop out are typical of although these abnormalities were not nearly as marked SSc. Indeed, in a patient presenting with Raynaud's as in the SSc group, nonetheless these did suggest that phenomenon these nailfold capillary abnormalities may PRP may not be an entirely vasospastic phenomenon. be the best indicator of underlying connective tissue However, it could be argued that by concentrating on disease [2] . Video capillaroscopy is an extension of the the most abnormal capillary our findings were not truly widefield technique which allows quantitation of these representative of the nailfold capillary bed. Therefore, abnormalities: using a video camera and digitizing the aim of the current study was to assess capillary system, dimensions of individual capillaries can be measdimensions as averaged from all visible capillaries in a ured, thus offering the potential of a non-invasive tech-3 mm length of the nailfold from both ring fingers, nique which should allow objective assessment of examining patients with PRP and SSc [subdivided into microvascular disease and its progression. We have those with limited cutaneous SSc (LSSc) and diffuse previously reported our initial experience of video capilcutaneous SSc (DSSc)] and healthy control subjects. In laroscopy, when we measured dimensions of the largest our previous study we did not subdivide SSc patients capillary in nine patients with primary Raynaud's pheinto two subgroups: a secondary aim of the present study was to test the hypothesis that capillary abnormalities would be more marked in those patients with LSSc Patients and methods time and reproducing the capillaries by hand on a grid which showed how many capillaries were to be measPatients ured. This was done at ×200 magnification. The groups of patients/controls were as follows. Clinical A magnification of ×600 was then used to find the characteristics are shown in Table 1: 'start' capillary and to measure the capillary dimensions. (1) 20 healthy control subjects; For this part of the procedure the snapshot mode of the (2) 15 patients with PRP. All patients with PRP gave Capiflow software was used, giving a picture on the a history of typical triphasic colour changes on cold video screen of a single capillary. Capillary density was exposure of at least 2 yr duration, and had no determined by counting the total number of capillaries clinical or immunological evidence of underlying in the 3 mm length, and a mean result taken from right connective tissue disease. In particular, none had and left hands. The dimensions measured in each capilsclerodactyly or digital pitting; lary were as follows ( Fig. 1) : the arterial diameter of (3) 13 patients with DSSc. These patients had skin the capillary (a), the venous diameter of the capillary involvement extending proximal to elbows and (v), the width of the capillary at its apex, or 'apical loop knees;
diameter' (l ) and the total capillary width at its widest (4) 21 patients with LSSc. These patients had scleropoint or 'total loop diameter' (t).
Although by definition total capillary width could be derma limited to distal to the elbow, knee and neck.
measured for all capillaries in the 3 mm length (otherwise All SSc patients fulfilled the American Rheumatism that capillary would not be 'counted'), in some instances Association criteria for the disease [4] . the arterial, venous and apical loop diameters could not be calculated for each capillary, usually because the Video capillaroscopy capillary was too indistinct or too tortuous. Therefore, Patients and controls were asked to refrain from smokfor each individual, the number of capillaries in which ing and caffeine-containing drinks for 4 h prior to examall dimensions could be measured was also documented ination. Each patient/control was acclimatized for ( Table 2 ). We felt it important to calculate total capillary 20 min at a room temperature of 23°C prior to video width in all capillaries (not only those in which arterial, capillaroscopy. The ring finger of each hand was venous and apical loop dimensions could be measured): examined.
otherwise the total capillary width would be falsely low Capillaroscopy equipment. The capillaroscopy equipin patients with very distorted capillary architecture (as ment includes a dissecting microscope with two interthe most abnormal capillaries would be excluded from changeable lenses giving magnifications of ×200 and analyses). ×600. A Flexilux 300 long-life fibreoptic light source Therefore, for each individual, the number of capillarand filter (Scholly Fibreoptic GmbH, Germany; model ies from which the value for total capillary width was D-7819 denzlingen) provides cold illumination. The derived equalled the number/3 mm, whereas the number video camera used with the microscope is the Moritex from which the arterial, venous and apical loop diaEuropa Ltd, UK camera, model MS-500. This allows meters was derived was usually smaller. For each indithe image of the nailfold capillaries to be captured and vidual studied a mean value for each of the above transferred in an analogue format to a Hitachi M930E dimensions was recorded, by averaging the results from video cassette recorder. The capillaries are projected all capillaries in right and left index fingers. from the video cassette recorder on to a 14 inch television Measurement of inter-and intra-observer variability. screen which is connected to a personal computer. The All measurements were originally performed by a vascusoftware used is Capiflow software as developed by the lar flow technician (TM ). After this initial analysis the Karolinska Institute for Microelectronics and stored videotapes from 18 subjects (spread across all Diagnostika HB (Stockholm, Sweden). This software four control/patient groups) were reanalysed to allow enables the image on the television screen to be analysed.
calculation of intra-observer variability. To calculate Measurement of capillary dimensions. The dimensions inter-observer variability, a clinician (MB) reanalysed of nailfold capillaries from both right and left ring 23 (spread across all groups) of the stored videotapes. fingers were measured. A length of 3 mm of the distal For each 'reanalysis', the observer attempted to find the capillary row was defined by finding an arbitrary 'start' same 'start' capillary from the sketch of capillary morphology drawn when the capillaries were first measured. capillary and then measuring 3 mm on the screen by T 1. Clinical characteristics of patients and controls
Age (yr) 38 ± 13 40 ± 14 50 ± 12 45 ± 13 P = 0. 
19.6 ± 3.6 22.1 ± 3.7 13.3 ± 5.5 12.7 ± 4.4 P = 0.38
Values are mean ± .. for number per 3 mm and geometric mean [CV ] for measurements. Comparisons are adjusted for age. Number/3 mm (a, v, l ) relates to the number of capillaries adequately visualized to allow measurement of arterial diameter (a), venous diameter (v) and apical loop diameter (l ). Number/3 mm (t) is capillary density-the number of capillary loops/3 mm. In all of these capillaries, total loop diameter (t) could be measured.
However, sometimes it was difficult to be certain that on the pooled variance from the analysis of covariance. All dimensions were log transformed prior to analysis the same 'start' capillary had been identified on each to achieve normality and the results are reported as occasion.
geometric mean with coefficient of variation (CV ).
Statistical analysis
Intra-and inter-observer reproducibility were assessed using Pearson's correlation, and bias with limits of Demographic data were compared across the groups agreement [5]. using analysis of variance (age), the chi-squared test (sex, smoking) or Kruskal-Wallis non-parametric analysis of variance. Density and dimensions were compared Results across groups using analysis of covariance, adjusted for
Between-group comparisons age, sex and smoking status. Three pre-planned comparisons were carried out between the four groups (PRP vs
The results are shown in Table 2 and Fig. 2 . There were a surprisingly large number of smokers in the controls, PRP vs SSc, LSSc vs DSSc): these were based
F. 2. Capillary density (A) and arterial (B), venous (C ), apical loop (D) and total loop diameter (E) in healthy control subjects and patients with PRP, LSSc and DSSc.
three patient groups ( Table 1) , but the results were significantly larger in patients with LSSc than in patients with DSSc, although capillary density was adjusted for smoking as well as for age and sex. There were significant trends for capillary dimensions to rise similar. Gender had no significant effect on the results across groups, healthy controls having the smallest dimensions and patients with LSSc having the largest (P > 0.75 for all measurements). These dimensions are smaller than those previously (P < 0.0001 for all dimensions). Capillary density was significantly lower, and dimensions larger, in patients published in abstract form [6, 7] . This is because of a previously unrecognized fault in the computing of the with SSc compared with patients with PRP. Although dimensions were larger in patients with PRP than in nailfold dimensions, suggesting a magnification of ×450 instead of ×600. This fault also affected the analysis of healthy controls, differences were not statistically significant, and capillary density did not differ between the results in our previously published paper [3] , but because the fault was consistent the analysis of comparipatients with PRP and controls. Dimensions were sons between groups is not affected, only the absolute method of evaluation than in our previous study, in which we chose the largest capillary of the distal row. measurements.
The technique of video capillaroscopy facilitates the Reproducibility-intra-and inter-observer quantitation of the nailfold capillary abnormalities which have been long recognized in patients with conThis is shown in Table 3 . Repeated measurements by the same observer ( TM2) and a different observer (MB) nective tissue disease [1] . Because images are recorded on video, images can be stored for analysis and reanawere highly correlated with the original measurements ( TM1), but the limits of agreement were between lysis (as in this study). So far only a small number of studies have applied this technique in patients with ±25-50%, indicating lack of reproducibility. The actual measurements showed small, but often statistically sigprimary and secondary Raynaud's. There is also the potential to extend the technique of capillary dimensions are larger in patients with PRP compared with healthy controls, this was only a trend video capillaroscopy to examine red blood cell velocity in response to a dynamic challenge such as cooling that was not statistically significant and differences between the two groups were small. Nonetheless these [13] [14] [15] and to examine capillary permeability [16, 17] . The study by Studer et al. included measurement of the findings lend some further support to our previous suggestion that PRP is not an entirely benign vasospastic 'stop-flow duration' [12] . A larger number of studies quantified nailfold capilphenomenon, but may be associated with subtle microcirculatory changes. In the present study we averaged lary abnormalities using primarily the widefield technique without continuous recording. Different methods dimensions across all measurable capillaries in two 3 mm lengths of nailfold-one from the left and one from the of quantifying capillary abnormalities have included the following: the number of capillaries in the distal row right ring finger. This would seem to be a more objective T 3. Intra-and inter-observer variability in measurement of capillary density and dimensions
Intra-observer
Inter-observer
Number/3 mm (a, v, l) r = 0.88, P < 0.001 −2.3 (− 7.9, +3.3) P = 0.003 r = 0.84, P < 0.001 −1.9 (− 7.7, +3.8) P = 0.004 Arterial diameter ( mm) r = 0.98, P < 0.001 −7% (− 25%, +15%) P = 0.009 r = 0.82, P < 0.001 −7% (− 39%, +43%) P = 0.13 Venous diameter (mm) r = 0.98, P < 0.001 −6% (− 27%, +22%) P = 0.07 r = 0.86, P < 0.001 −5% (− 34%, +38%) P = 0.23 Apical loop diameter ( mm) r = 0.99, P < 0.001 −4% (− 23%, +19%) P = 0.11 r = 0.76, P < 0.001 −7% (− 44%, +52%) P = 0.15 Number/3 mm (t) r = 0.61, P < 0.005 −3.3 (− 11.2, +4.5) P = 0.002 r = 0.73, P < 0.001 −3.0 (− 8.7, +2.7) P < 0.001 Total loop diameter ( mm) r = 0.89, P < 0.001 −5% (− 39%, +49%) P = 0.34 r = 0.86, P < 0.001 −1% (− 29%, +38%) P = 0.74
Values are bias ( limits of agreement); for the measurements a, v, l and t these are expressed as a percentage, whereas for the numbers per 3 mm, these are absolute numbers. Number/3 mm (a, v, l) relates to the number of capillaries adequately visualized to allow measurement of arterial diameter (a), venous diameter (v) and apical loop diameter (l ). Number/3 mm (t) is capillary density-the numbr of capillary loops/3 mm. In all of these capillaries, total loop diameter (t) could be measured. measured over 5 mm [18] ; an index derived from capilimproved image analysis programmes, are now required to elucidate whether video capillaroscopy might be a lary apex width and maximum limb width [19] ; afferent and efferent luminal diameters [20] ; the mean diameter useful tool in the assessment of disease progression. of the capillary loops, averaged across the whole nailfold, and capillary density [21] ; mean capillary surface tortuous capillaries, at which point to measure dimencapillary dimensions in patients with primary Raynaud's sions. To gain insight into this subjective element of the phenomenon, limited cutaneous systemic sclerosis, diffuse analysis, we studied both intra-observer and inter- showed that the usefulness of video microscopy is some- sions in different patient groups prospectively, using
